We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bayer AG | TG:BAYN | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.055 | -0.19% | 28.495 | 28.44 | 28.50 | 28.73 | 28.26 | 28.565 | 190,362 | 20:49:09 |
From May 2019 to May 2024
By Cecilia Butini
Bayer AG said Tuesday that it has entered into a development-and-license agreement with U.K.-based company Blackford Analysis Ltd. to build a digital platform for medical imaging.
Under the agreement, Bayer will create artificial intelligence-enabled solutions to power the platform, which should allow health-care professionals to manage digital-clinical imaging. The platform will provide access to diagnostic imaging analysis applications, protocol management tools and AI algorithms, giving physicians the potential to increase efficiency and reduce errors, the German chemical and pharmaceutical conglomerate said.
Blackford Analysis will provide the underlying technology for Bayer to develop its digital solutions, it added.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
December 01, 2020 10:13 ET (15:13 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
